Evaluation of a New Open Source Virtual Bronchoscope Navigation System

Status Suspended

Clinical Trial Summary

To evaluate the feasibility of the Fraxinus Virtual Bronchoscope Navigation (VBN) System in the bronchoscopic access to target lesions. The study emphasizes the system´s efficacy in diagnostics of peripheral pulmonary lesions and the ease of use for the operator.

Clinical Trial Description

Multi-center study. The study explores Fraxinus which is an open source, software only, simple guiding system for bronchoscopy. The system provides 3D maps with centerline-to-target information extracted from preoperative computed tomography. The ability of the system to guide a user to a peripheral target lesion will be evaluated. During bronchoscopy any established method for diagnostic sampling is allowed. User Evaluation will be essential to decide if the Fraxinus VBN System is beneficial in a clinical setting. ;

Study Design

Related Conditions & MeSH terms

Bronchial Neoplasms

Clinical Trial Details

NCT number	NCT03745859
Study type	Observational
Source	Norwegian University of Science and Technology
Contact
Status	Suspended
Phase
Start date	November 19, 2018
Completion date	October 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02909452` - Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT02493023` - Automatic CT-to-patient Registration During Navigated Bronchoscopy and EBUS	N/A
Terminated	`NCT02050724` - ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT	Phase 2
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Recruiting	`NCT02804100` - Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients	N/A
Active, not recruiting	`NCT05241873` - (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations	Phase 1/Phase 2
Completed	`NCT03037385` - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT04862780` - (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC	Phase 1/Phase 2
Not yet recruiting	`NCT06376084` - Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Recruiting	`NCT03402048` - The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial	Phase 3
Recruiting	`NCT02264210` - Icotinib for Completed Resected IB NSCLC With EGFR Mutation	Phase 2
Terminated	`NCT05153408` - (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC	Phase 1
Completed	`NCT01261585` - Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT	N/A
Recruiting	`NCT06177925` - A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC	Phase 2
Completed	`NCT02897778` - Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors	Phase 1
Completed	`NCT03516214` - EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations	Phase 1
Completed	`NCT02745002` - Navigated EBUS and Functional Imaging in Lung Cancer	N/A